Angelman Syndrome Foundation opener
  • Walk
  • Contact Registry
  • News
  • Blog
DOnate
  • What is Angelman Syndrome
    • Symptoms and Causes
    • Testing and Diagnosis
    • Genetics of AS
    • Photo Gallery
  • For Parents
    • Newly Diagnosed
    • Accomplishments of Individuals
    • Participate in Research Studies
    • Angelman Therapeutics
  • Research
    • ASF Funded Research
    • Call for Proposals
    • Current Research Studies
    • Research Funding Philosophy
  • Make an Impact
    • ASF Cure Club
    • Ways To Donate
    • Fundraising for ASF
    • ASF Committees
    • Shop & Support ASF
    • Volunteer Opportunities
  • AS Clinics
    • AS Clinic Patient Survey
  • Resources
    • Search by Topic
    • Adult Resources
    • ASF Family Resource Team
    • ASF Family Fund
    • ASF Family Champions
    • Angelman Syndrome A to Z
    • Communication Training Series
    • Behaviors Training Series
    • Educational Webinars
    • IEP Bank
    • International AS Resources
    • Federal Resources
    • Seizures
    • State Resources
  • Events
    • ASF Walk
      • ASF Walk Sponsors
    • Conferences and Symposia
    • Bank of America Chicago Marathon
  • About
    • Contact ASF
    • Contact Registry
    • History
    • Board of Directors
    • Communication Advisory Committee
    • Scientific Advisory Committee
    • Receive Our Emails
    • Privacy
    • Financial Transparency
Ron Thibert

articles and announcements

Categories: Clinical Trial

Ron Thibert
January 23, 2020

Low Glycemic Index Therapy (LGIT) for the Treatment of Epilepsy in Angelman Syndrome

$28,850 ASF has supported varied initiatives to improve treatment of seizures in AS and this grant aimed at exploring alternatives to the use of the very restrictive ketogenic diet. In the low glycemic diet, the extremely high lipid content of […]

Read more
December 22, 2019

Levodopa/carbidopa treatment of children with Angelman Syndrome

$72,855 ASF has previously supported work at understanding if levodopa might have a potential therapeutic role in AS. This grant provides partial support to a larger clinical trial study which is aimed at implementing a controlled trial of levodopa supplementation […]

Read more

Recent Posts

  • Joint Initiative between ASA and ASF
  • Groundbreaking ASF Funded Research on Gene Therapy in AS Published in Nature
  • Ovid Therapeutics Collaborates with UCONN Health and Stormy Chamberlain, PhD to Develop Gene Therapy for AS
  • CASS and ASF Announce Collaboration to Increase Support for Families 
  • Ben Philpot, PhD Partners with Deerfield and Pinnacle Hill

Browse

  • What is Angelman Syndrome
  • For Parents
  • ASF Funded Research
  • Make an Impact
  • Angelman Syndrome Clinic Network
  • Events
  • About
  • Resources & Education
  • Contact Registry
  • News
Address Angelman Syndrome Foundation
3015 E. New York Street
Suite A2 #285
Aurora, IL 60504
Phone800.432.6435 Emailinfo@angelman.org

Connect

  • facebook
  • twitter
  • linkedin
  • instagram
  • pinterest
  • rss
  • youtube

The Mission

The mission of the Angelman Syndrome Foundation is to advance the awareness and treatment of Angelman syndrome through education and information, research, and support for individuals with Angelman syndrome, their families and other concerned parties. We exist to give all of them a reason to smile, with the ultimate goal of finding a cure.

Copyright © 2021 Angelman Syndrome Foundation. ALL Rights Reserved. | Site design: BRAND INSPIRATION, LLC